Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD14

CD14

Brief Information

Name:Monocyte differentiation antigen CD14
Target Synonym:CD14,CD14 Molecule,Myeloid Cell-Specific Leucine-Rich Glycoprotein,CD14 Antigen,Monocyte Differentiation Antigen CD14
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

CD4-H5252-MALS-HPLC
Human CD14, Fc Tag (Cat. No. ) MALS images

The purity of Human CD14, Fc Tag (Cat. No. CD4-H5252) is more than 90% and the molecular weight of this protein is around 126-155 kDa verified by SEC-MALS.

  • Background
    Cluster of differentiation 14 (CD14), is a cell surface glycoprotein, and is a is a component of the innate immune system. CD14 is a myelomonocytic differentiation antigen preferentially expressed on monocytes, macrophages, and activated granulocytes. CD14 exists in two forms. Either it is anchored into the membrane by a glycosylphosphatidylinositol tail (mCD14) or it appears in a soluble form (sCD14). Soluble CD14 either appears after shedding of mCD14 (48 kDa) or is directly secreted from intracellular vesicles (56 kDa). CD14 acts as a co-receptor (along with the Toll-like receptor TLR 4 and MD-2) for the detection of bacterial lipopolysaccharide (LPS). CD14 can bind LPS only in the presence of lipopolysaccharide-binding protein (LBP). CD14 has been proposed to be involved in various biological processes, including transportation of other lipids, cell-cell interaction during different immune responses, as well as recognition of apoptotic cells. Although LPS is considered its main ligand, CD14 also recognizes other pathogen-associated molecular patterns. CD14+ cells are monocytes that can differentiate into a host of different cells. CD14 has been shown to interact with Lipopolysaccharide-binding protein.
  • Clinical and Translational Updates
      
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

    CD4-H5228-MALS-HPLC
    Human CD14, His Tag (Cat. No. ) MALS images

    The purity of Human CD14, His Tag (Cat. No. CD4-H5228) is more than 90% and the molecular weight of this protein is around 44-58 kDa verified by SEC-MALS.

Synonym Name

CD14

Background

Cluster of differentiation 14 (CD14), is a cell surface glycoprotein, and is a is a component of the innate immune system. CD14 is a myelomonocytic differentiation antigen preferentially expressed on monocytes, macrophages, and activated granulocytes. CD14 exists in two forms. Either it is anchored into the membrane by a glycosylphosphatidylinositol tail (mCD14) or it appears in a soluble form (sCD14). Soluble CD14 either appears after shedding of mCD14 (48 kDa) or is directly secreted from intracellular vesicles (56 kDa). CD14 acts as a co-receptor (along with the Toll-like receptor TLR 4 and MD-2) for the detection of bacterial lipopolysaccharide (LPS). CD14 can bind LPS only in the presence of lipopolysaccharide-binding protein (LBP). CD14 has been proposed to be involved in various biological processes, including transportation of other lipids, cell-cell interaction during different immune responses, as well as recognition of apoptotic cells. Although LPS is considered its main ligand, CD14 also recognizes other pathogen-associated molecular patterns. CD14+ cells are monocytes that can differentiate into a host of different cells. CD14 has been shown to interact with Lipopolysaccharide-binding protein.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Atibuclimab IC-14 Phase 2 Clinical Icos Corporation Motor Neuron Disease; Pneumonia; Sepsis; Coronavirus Disease 2019 (COVID-19); Arrhythmogenic Right Ventricular Dysplasia; Respiratory Distress Syndrome, Adult; Lung Diseases; Cardiomyopathies; Arrhythmias, Cardiac; Amyotrophic Lateral Sclerosis; Dengue Details
TCP-25 TCP-25 Phase 1 Clinical Vaxinnate Blister; Epidermolysis Bullosa; Wounds and Injuries Details
Atibuclimab IC-14 Phase 2 Clinical Icos Corporation Motor Neuron Disease; Pneumonia; Sepsis; Coronavirus Disease 2019 (COVID-19); Arrhythmogenic Right Ventricular Dysplasia; Respiratory Distress Syndrome, Adult; Lung Diseases; Cardiomyopathies; Arrhythmias, Cardiac; Amyotrophic Lateral Sclerosis; Dengue Details
TCP-25 TCP-25 Phase 1 Clinical Vaxinnate Blister; Epidermolysis Bullosa; Wounds and Injuries Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message